ArticleInfection prevention in practice2026
Clonal dissemination of linezolid-resistant
Article in Infection prevention in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Linezolid-resistant Methods: Clinical isolates of Findings: In total, 24 patients with at least one clinical LRSE isolate were identified. WGS analysis confirmed that all isolates belonged to a single clone, exhibiting one to 50 single-nucleotide polymorphism differences over a 46-month period. EpiLinx revealed overlapping hospital admissions, facilitating direct transmission. All patients had invasive devices. The Department of Surgical Gastroenterology exhibited notably high linezolid usage than the hospital average at 144.3 DDD/month, accounting for 20% of total hospital consumption. Conclusion: The outbreak was characterized by clonal dissemination of LRSE, strongly associated with elevated linezolid usage in the Department of Surgical Gastroenterology. These findings underscore the critical impact of departmental antibiotic consumption on the emergence and spread of resistant organisms, and highlight the value of real-time genomic surveillance and digital epidemiological tools in outbreak management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.